Literature DB >> 26341967

Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.

Hajime Matsushima1, Tamotsu Kuroki1, Amane Kitasato1, Tomohiko Adachi1, Takayuki Tanaka1, Masataka Hirabaru1, Takanori Hirayama1, Naoki Kuroshima1, Masaaki Hidaka1, Akihiko Soyama1, Mitsuhisa Takatsuki1, Naoe Kinoshita2, Kazunori Sano3, Noriyuki Nishida3, Susumu Eguchi4.   

Abstract

BACKGROUND: Intrahepatic cholangiocarcinomas develop through a multi-step carcinogenesis. Precancerous lesions are defined as biliary intraepithelial neoplasia. Sex determining region Y-box9 (Sox9) is required for the normal differentiation of the biliary tract. AIMS: To evaluate the Sox9 expression in carcinogenesis and its correlation with clinicopathological features in intrahepatic cholangiocarcinoma.
METHODS: Sox9 expression in normal epithelium, biliary intraepithelial neoplasia, and intrahepatic cholangiocarcinoma were investigated immunohistochemically using 43 specimens of intrahepatic cholangiocarcinoma. Sox9 expression in intrahepatic cholangiocarcinoma was compared with the clinicopathological features. The molecular effects of Sox9 were investigated by gene transfection to intrahepatic cholangiocarcinoma cell lines.
RESULTS: Sox9 expression was decreased from the normal epithelium to the biliary intraepithelial neoplasia in a stepwise fashion. In 51.2% (22/43) of the patients with intrahepatic cholangiocarcinoma, Sox9 expression was positive, and Sox9 expression was significantly associated with the biliary infiltration (P=0.034) and poor overall survival (P=0.039). Upregulation of Sox9 promoted the cell migration and invasion, and decreased the E-cadherin expression and increased the vimentin and α-SMA expression in cell lines.
CONCLUSIONS: Decreased Sox9 expression may be related to the early stage of the carcinogenesis of intrahepatic cholangiocarcinoma. Sox9 overexpression in intrahepatic cholangiocarcinoma is related to biliary infiltration and poorer prognosis, and it promotes cell migration and invasion, via the epithelial-to-mesenchymal transition.
Copyright © 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biliary intraepithelial neoplasia; Intrahepatic cholangiocarcinoma; Sox9

Mesh:

Substances:

Year:  2015        PMID: 26341967     DOI: 10.1016/j.dld.2015.08.003

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  14 in total

Review 1.  Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  Gene Expr       Date:  2017-10-25

2.  Expression of SOX9 Is Related to Prognosis in Patients with Oesophageal Squamous Cell Carcinoma.

Authors:  Naotomo Higo; Hiroshi Okumura; Yasuto Uchikado; Itaru Omoto; Ken Sasaki; Yoshiaki Kita; Desaki Ryosuke; Masahiro Noda; Tetsuhiro Owaki; Sumiya Ishigami; Shoji Natsugoe
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

3.  SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.

Authors:  Georg Richtig; Ariane Aigelsreiter; Daniela Schwarzenbacher; Anna Lena Ress; Jan Basri Adiprasito; Verena Stiegelbauer; Gerald Hoefler; Silvia Schauer; Tobias Kiesslich; Peter Kornprat; Thomas Winder; Florian Eisner; Armin Gerger; Herbert Stoeger; Rudolf Stauber; Carolin Lackner; Martin Pichler
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

4.  SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance.

Authors:  Xiaodong Yuan; Jun Li; Cédric Coulouarn; Tao Lin; Laurent Sulpice; Damien Bergeat; Carolina De La Torre; Roman Liebe; Norbert Gretz; Matthias P A Ebert; Steven Dooley; Hong-Lei Weng
Journal:  Br J Cancer       Date:  2018-11-13       Impact factor: 7.640

5.  A novel prognostic model for diagnosing atypical bile duct hyperplasia in patients with intrahepatic lithiasis.

Authors:  Hongcheng Lu; Hao Yang; Linquan Wu; Wenjun Liao; Xianping He; Enliang Li; Rongshou Wu; Shidai Shi; Zhilong Yang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma.

Authors:  Hua Yu; Han Wang; Wei Dong; Zhen-Ying Cao; Rong Li; Chao Yang; Wen-Ming Cong; Hui Dong; Guang-Zhi Jin
Journal:  PeerJ       Date:  2020-01-27       Impact factor: 2.984

Review 7.  Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  J Clin Med       Date:  2015-12-19       Impact factor: 4.241

8.  Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma.

Authors:  Céline Demarez; Catherine Hubert; Christine Sempoux; Frédéric P Lemaigre
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

9.  Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.

Authors:  Haihua Ruan; Shuangyan Hu; Hongyu Zhang; Gang Du; Xiaoting Li; Xiaobo Li; Xichuan Li
Journal:  Oncotarget       Date:  2017-11-06

Review 10.  Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link.

Authors:  Chaobo Chen; Leonard J Nelson; Matías A Ávila; Francisco Javier Cubero
Journal:  Cells       Date:  2019-09-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.